Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood.
Saved in:
| Title: | Development of a standardized and validated flow cytometry approach for monitoring of innate myeloid immune cells in human blood. |
|---|---|
| Authors: | van der Pan K; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Bruin-Versteeg S; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Damasceno D; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Hernández-Delgado A; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., van der Sluijs-Gelling AJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., van den Bossche WBL; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Department of Immunology, Department of Neurosurgery, Brain Tumor Center, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, Netherlands., de Laat IF; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Díez P; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Naber BAE; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Diks AM; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Berkowska MA; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Mooij B; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Groenland RJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Bie FJ; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Khatri I; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Kassem S; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., de Jager AL; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Louis A; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Almeida J; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., van Gaans-van den Brink JAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Barkoff AM; Institute of Biomedicine, Research Center for Infections and Immunity, University of Turku (UTU), Turku, Finland., He Q; Institute of Biomedicine, Research Center for Infections and Immunity, University of Turku (UTU), Turku, Finland., Ferwerda G; Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands., Versteegen P; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Berbers GAM; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands., Orfao A; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., van Dongen JJM; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Teodosio C; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands.; Translational and Clinical Research Program, Cancer Research Center (IBMCC; University of Salamanca - CSIC), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca, and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2022 Sep 14; Vol. 13, pp. 935879. Date of Electronic Publication: 2022 Sep 14 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
